研究领域

肿瘤发生机制，肿瘤放化疗抗性研究，肿瘤放化疗与免疫治疗

近期论文

Guo X, Bai Y, Zhao M, Zhou M, Shen Q, Caihong Yun，Zhang H, Zhu WG, Wang J*. Acetylation of 53BP1 Dictates the DNA Double Strand Break Repair Pathway.Nucleic Acids Res. 2018 Jan 25;46(2):689-703. (Article , IF:10.2)
Zhao M, Geng R, Guo X, Yuan R, Zhou X, Zhong Y, Huo Y, Zhou M, Shen Q, Li Y, Zhu W,Wang J*. PCAF/GCN5-Mediated Acetylation of RPA1 Promotes Nucleotide Excision Repair. Cell Rep. 2017 Aug 29;20(9):1997-2009. (Article , IF:8.2)
Li F, Zhu T, Cao B,Wang J*, Liang L*. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance. Eur J Cancer. 2017 Oct;84:184-192. (Article , IF:6.2).
Wang J#,Aroumougame A, Lobrich M, Li Y, Chen D, Chen J*, Gong Z*. Artemis to dictate DNA repair pathway choice. Genes & Dev.2014 Dec 28(24):2693-8. (Article , IF:12.6
Wang J#, Chen J*, Gong Z*. TopBP1 controls BLM protein level to maintain genome stability. Mol Cell. 2013 Dec 12;52(5):667-78. (Article , IF:14.6)